Source: BioPortfolio

Vortex: Stratec Vortex sign deal on microfluidic chip for VTX1 liquid biopsy system

This chip is a key component of the VTX1 instrument an automated liquid biopsy platform which provides a simple label free isolation of circulating tumor cells directly from The post Stratec Vortex sign deal on microfluidic chip for VTX1 liquid biopsy syst...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Andreas Hestbeck's photo - CEO of Vortex

CEO

Andreas Hestbeck

CEO Approval Rating

86/100